Tourmaline Bio Inc (TRML)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | N/A | N/A | 38,978 |
| Other current assets | 0 | 0 | 1,816 |
| TOTAL | $N/A | $N/A | $40,794 |
| Non-Current Assets | |||
| PPE Net | N/A | N/A | 2,923 |
| Other Non-Current Assets | 0 | 0 | 20 |
| TOTAL | $N/A | $N/A | $2,943 |
| Total Assets | $N/A | $N/A | $41,942 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 0 | 0 | 667 |
| Accrued Expenses | N/A | N/A | 1,623 |
| TOTAL | $N/A | $N/A | $2,291 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 0 | 0 | 56,753 |
| TOTAL | $N/A | $N/A | $56,753 |
| Total Liabilities | $N/A | $N/A | $59,044 |
| Shareholders' Equity | |||
| Common Shares | N/A | N/A | 1 |
| Retained earnings | N/A | N/A | -20,307 |
| TOTAL | $N/A | $N/A | $-17,102 |
| Total Liabilities And Equity | $0 | $0 | $41,942 |